1 |
Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
DOI
|
2 |
Shi, Y. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470.
DOI
|
3 |
Shtilbans, V., M. Wu, and D. E. Burstein. 2010. Evaluation of apoptosis in cytologic specimens. Diagn. Cytopathol. 38, 685-697.
DOI
|
4 |
Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, and S. J. Martin. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
DOI
|
5 |
Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
DOI
|
6 |
Liu, X., C. N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
DOI
|
7 |
Loeb, L. A., K. R. Loeb, and J. P. Anderson JP. 2003. Multiple mutations and cancer. Proc. Natl. Acad. Sci. USA 100, 776-781.
DOI
|
8 |
Lu, B., X. Wu, Y. Dong, J. Gong, and Y. Zhang. 2009. Mutagenicity and safety evaluation of ethanolic extract of Prunus mume. J. Food Sci. 74, T82-88.
DOI
|
9 |
Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490.
DOI
|
10 |
Meiler, J., and M. Schuler. 2006. Therapeutic targeting of apoptotic pathways in cancer. Curr. Drug. Targets 7, 1361-1369.
DOI
|
11 |
Miyazawa, M., H. Utsunomiya, K. Inada, T. Yamada, Y. Okuno, H. Tanaka, and M. Tatematsu. 2006. Inhibition of Helicobacter pylori motility by (+)-Syringaresinol from unripe Japanese apricot. Biol. Pharm. Bull. 29, 172-173.
DOI
|
12 |
Mori, S., T. Sawada, T. Okada, T. Ohsawa, M. Adachi, and K. Keiichi. 2007. New anti-proliferative agent, MK615, from Japanese apricot "Prunus mume" induces striking autophagy in colon cancer cells in vitro. World J. Gastroenterol. 13, 6512-6517.
DOI
|
13 |
Nakagawa, A., T. Sawada, T. Okada, T. Ohsawa, M. Adachi, and K. Kubota. 2007. New antineoplastic agent, MK615, from UME (a Variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Breast J. 13, 44-49.
DOI
|
14 |
Han, S. I., Y. S. Kim, and T. H. Kim. 2008. Role of apoptotic and necrotic cell death under physiologic conditions. BMB Rep. 41, 1-10.
DOI
|
15 |
Harris, M. H. and C. B. Thompson. 2000. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7, 1182-1191.
DOI
|
16 |
Jin, Z. and W. S. El-Deiry. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163.
DOI
|
17 |
Kekre, N., C. Griffin, J. McNulty, and S. Pandey. 2005. Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother. Pharmacol. 56, 29-38.
DOI
|
18 |
Khan, N., V. M. Adhami, and H. Mukhtar. 2008. Apoptosis by dietary agents for prevention and treatment of cancer. Biochem. Pharmacol. 76, 1333-1339.
DOI
|
19 |
Korsmeyer, S. J. 1999. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693s-1700s.
|
20 |
Kim, B. J., J. H. Kim, H. P. Kim, and M. Y. Heo. 1997. Biological screening of 100 plant extracts for cosmetic use (II): anti-oxidative activity and free radical scavenging activity. Int. J. Cosmet. Sci. 19, 299-307.
DOI
|
21 |
Kroemer, G. and J. C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6, 513-519.
DOI
|
22 |
Lawen, A. 2003. Apoptosis-an introduction. Bioessays 25, 888-896.
DOI
ScienceOn
|
23 |
Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
DOI
|
24 |
Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
DOI
|
25 |
Danial, N. N. and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell 116, 205-219.
DOI
|
26 |
De Laurenzi, V. and G. Melino. 2000. Apoptosis. The little devil of death. Nature 406, 135-136.
DOI
|
27 |
Deveraux, Q. L. and J. C. Reed. 1999. IAP family proteins- suppressors of apoptosis. Genes Dev. 13, 239-252.
DOI
|
28 |
Deveraux, Q. L., N. Roy, H. R. Stennicke, T. Van Arsdale, Q. Zhou, S. M. Srinivasula, E. S. Alnemri, G. S. Salvesen, and J. C. Reed. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223.
DOI
|
29 |
Deveraux, Q. L., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304.
DOI
|
30 |
Fesik, S. W. 2005. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5, 876-885.
DOI
|
31 |
Fulda, S. and K. M. Debatin. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
DOI
|
32 |
Gao, Z., Y. Tian, J. Wang, Q. Yin, H. Wu, Y. M. Li, and X. Jiang. 2007. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. J. Biol. Chem. 282, 30718-30727.
DOI
|
33 |
Gilliland, D. G., C. T. Jordan, and C. A. Felix. 2004. The molecular basis of leukemia. Hematology Am. Soc. Hematol. Educ. Program 80-97.
|
34 |
Gupta, S. 2003. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int. J. Oncol. 22, 15-20.
|
35 |
Hacki, J., L. Egger, L. Monney, S. Conus, T. Rossé, I. Fellay, and C. Borner. 2000. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 19, 2286-2295.
DOI
|
36 |
Abramson, N. and B. Melton. 2000. Leukocytosis: basics of clinical assessment. Am. Fam. Physician. 62, 2053-2060.
|
37 |
Choi, H. J., O. H. Kang, P. S. Park, H. S. Chae, Y. C. Oh, Y. S. Lee, J. G. Choi, G. H. Lee, O. H. Kweon, and D. Y. Kwon. 2007. Mume fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages. J. Med. Food 10, 460-466.
DOI
|
38 |
Ashkenazi, A. and V. M. Dixit. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255-260.
DOI
|
39 |
Burlacu, A. 2003. Regulation of apoptosis by Bcl-2 family proteins. J. Cell Mol. Med. 7, 249-257.
DOI
|
40 |
Chang, H., H. Lin, L. Yi, J. Zhu, Y. Zhou, M. Mi, and Q. Zhang. 2010. 3,6-Dihydroxyflavone induces apoptosis in leukemia HL-60 cells via reactive oxygen species-mediated p38 MAPK/JNK pathway. Eur. J. Pharmacol. 648, 31-38.
DOI
ScienceOn
|
41 |
Chuda, Y., H. Ono, M. Ohnishi-Kameyama, K. Matsumoto, T. Nagata, and Y. Kikuchi. 1999. Mumefural, citric acid derivative improving blood fluidity from fruit-juice concentrate of Japanese apricot (Prunus mume Sieb. et Zucc). J. Agric. Food Chem. 47, 828-831.
DOI
|
42 |
Yang, L., Z. Cao, H. Yan, and W. C. Wood. 2003. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63, 6815-6824.
|
43 |
Stennicke, H. R. and G. S. Salvesen. 1998. Properties of the caspases. Biochim. Biophys. Acta. 1387, 17-31.
DOI
|
44 |
Sun, S. Y., N. Jr Hail, and R. Lotan. 2004. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 96, 662-672.
DOI
|
45 |
Thomenius, M. J., N. S. Wang, E. Z. Reineks, Z. Wang, and C. W. Distelhorst. 2003. Bcl-2 on the endoplasmic reticulum regulates Bax activity by binding to BH3-only proteins. J. Biol. Chem. 278, 6243-6250.
DOI
|
46 |
Yingsakmongkon, S., D. Miyamoto, N. Sriwilaijaroen, K. Fujita, K. Matsumoto, W. Jampangern, H. Hiramatsu, C. T. Guo, T. Sawada, T. Takahashi, K. Hidari, T. Suzuki, M. Ito, Y. Ito, and Y. Suzuki. 2008. In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC). Biol. Pharm. Bull. 31, 511-515.
DOI
|
47 |
Peter, M. E. and P. H. Krammer. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26-35.
DOI
|
48 |
Okada, H., and T. W. Mak. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 4, 592-603.
DOI
|
49 |
Okada, T., T. Sawada, T. Osawa, M. Adachi, and K. Kubota. 2007. A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity. Hepatogastroenterology 54, 1770-1774.
|
50 |
Oliver, F. J., G. de la Rubia, V. Rolli, M. C. Ruiz-Ruiz, G. de Murcia, and J. M. Murcia. 1998. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 273, 33533-33539.
DOI
|
51 |
Roy, N., Q. L. Deveraux, R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914-6925.
DOI
|
52 |
Salvesen, G. S., and C. S. Duckett. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410.
DOI
|